LobbyingSick Cells lobbying by quarter
Sick Cells's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q1 2025; the issues it reports most are Budget/Appropriations and Health Issues.
Sick Cells
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $20K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$95K · 6 reports
- Health issues$75K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
Firms it paid
| Firm | ||
|---|---|---|
| Indigo Hill Strategies | $170K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Indigo Hill Strategies | $30K |
| 04/16for Q1 | Indigo Hill Strategies | $30K |
| 01/20for Q4 2025 | Indigo Hill Strategies | $30K |
| 25/10/17for Q3 2025 | Indigo Hill Strategies | $30K |
| 25/07/15for Q2 2025 | Indigo Hill Strategies | $30K |
| 25/04/09for Q1 2025 | Indigo Hill Strategies | $20K |
| 25/03/14for Q1 2025 | Indigo Hill Strategies | Under $5,000 |